Amiodarone Usage After Ischemic Ventricular Tachycardia Ablation
- Conditions
- ICD ShockVentricular TachycardiaIschemic Cardiomyopathy
- Interventions
- Procedure: Ventricular tachycardia ablation
- Registration Number
- NCT03244748
- Lead Sponsor
- Yuksek Ihtisas Hospital
- Brief Summary
Ventricular Tachycardia ablation in ischemic cardiomyopathy patients is required procedure in cases when anti-arrhythmic drugs failed. The concern is if adjunctive continuation amiodarone after ablation is needed.
- Detailed Description
Ischemic cardiomyopathy patients have implantable cardioverter defibrillators (ICD) to prevent arrhythmic deaths. Ventricular tachycardia (VT) events with frequent ICD interventions in ischemic cardiomyopathy patients is encountered frequently. Frequents ICD interventions is associated with worse outcomes. Anti-arrhythmic drugs ,mostly amiodarone, are given prevent ventricular arrhythmias and ICD interventions that may not be curative. Ablation of ventricular tachycardia is the suggested treatment when anti-drugs are without effect. After ablation of ventricular arrhythmia the continuation of amiodarone is not well elucidated.
In this study we aimed to enroll ischemic cardiomyopathy patients having frequent ICD interventions despite medical treatment. VT ablation is performed and patients divided into two groups; group one continues having amiodarone after ablation, group two does not have amiodarone after ablation. Both groups will be compared in terms of recurrence and death.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Ischemic cardiomyopathy patients applied with frequent ICD interventionor electrical storms and having ejection fraction below 50%. Frequent ICD defined as more than 1 ICD intervention within month. Electrical storm defined as more than 2 ICD intervention within one day.
Patients with cardiomyopathies other than ischemic etiology
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Group 1 Ventricular tachycardia ablation Patients underwent ablation and continued having amiodarone after the procedure Group 2 Ventricular tachycardia ablation Patients underwent ablation and not having amiodarone after the procedure
- Primary Outcome Measures
Name Time Method Major adverse cardiovascular events six months Death, ICD intervetion
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Turkiye Yuksek Ihtisas Training and Research Hospital
🇹🇷Ankara, Turkey